EUVIMEDEUVIMED entdecken
Crossref

EE486 SPENDING ON GENE THERAPIES FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA

Adam J. Raymakers, Aaron S. Kesselheim, William B. Feldman

Value in Health · 2026-06 · 29 (6) · S154

DOI: 10.1016/j.jval.2026.03.779 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Value in Health, 2026-06. Verfasst von Adam J. Raymakers und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Raymakers, A. J., Kesselheim, A. S., & Feldman, W. B. (2026). EE486 SPENDING ON GENE THERAPIES FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA. Value in Health, 29(6), S154. https://doi.org/10.1016/j.jval.2026.03.779

Vancouver

Raymakers AJ, Kesselheim AS, Feldman WB. EE486 SPENDING ON GENE THERAPIES FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA. Value in Health. 2026;29(6):S154. doi:10.1016/j.jval.2026.03.779

BibTeX
@article{Raymakers2026,
  author = {Raymakers, Adam J. and Kesselheim, Aaron S. and Feldman, William B.},
  title = {EE486 SPENDING ON GENE THERAPIES FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA},
  journal = {Value in Health},
  year = {2026},
  volume = {29},
  number = {6},
  pages = {S154},
  doi = {10.1016/j.jval.2026.03.779}
}
Kostenlos starten →